Deutsche Bank Ag\ Sage Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$6.38 - $9.3 $51,531 - $75,116	-8,077 Reduced 3.61%	215,905 $1.97 Million
Q1 2025 May 09, 2025	BUY	$5.55 - $8.66 $961,060 - $1.5 Million	173,164 Added 340.75%	223,982 $1.78 Million
Q4 2024 Jun 30, 2025	SELL	$4.78 - $8.57 $827,723 - $1.48 Million	-173,164 Reduced 77.31%	50,818 $275,000
Q4 2024 Feb 14, 2025	BUY	$4.78 - $8.57 $98,009 - $175,719	20,504 Added 67.64%	50,818 $275,000
Q3 2024 Jun 26, 2025	SELL	$7.02 - $13.08 $1.36 Million - $2.53 Million	-193,668 Reduced 86.47%	30,314 $218,000

Q3 2024 Nov 13, 2024	BUY	$7.02 - $13.08 $23,945 - $44,615	3,411 Added 12.68%	30,314 $218,000
Q2 2024 Jun 12, 2025	SELL	$10.58 - $17.9 $2.09 Million - $3.53 Million	-197,079 Reduced 87.99%	26,903 $292,000
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $10.6 Million - $18 Million	-1,003,592 Reduced 97.39%	26,903 $292,000
Q1 2024 Jun 02, 2025	BUY	$18.62 - $26.95 $15 Million - $21.7 Million	806,513 Added 360.08%	1,030,495 $19.3 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $51,018 - $73,843	2,740 Added 0.27%	1,030,495 $19.3 Million
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $9,336 - $12,153	-546 Reduced 0.05%	1,027,755 $22.3 Million
Q3 2023 Nov 09, 2023	SELL	$16.75 - $48.98 $107,870 - $315,431	-6,440 Reduced 0.62%	1,028,301 $21.2 Million
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $10.5 Million - $15.3 Million	257,328 Added 33.1%	1,034,741 $48.7 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $9.3 Million - $11.6 Million	249,494 Added 47.26%	777,413 $32.6 Million
Q4 2022 Feb 13, 2023	SELL	$32.2 - $43.61 $996,557 - $1.35 Million	-30,949 Reduced 5.54%	527,919 $20.1 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $293,392 - $393,281	-9,089 Reduced 1.6%	558,868 $21.9 Million
Q2 2022 Aug 11, 2022	SELL	$27.52 - $37.99 $313,315 - $432,516	-11,385 Reduced 1.97%	567,957 $18.3 Million
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $853,738 - $1.27 Million	-27,800 Reduced 4.58%	579,342 $19.2 Million
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $924,461 - $1.18 Million	-24,945 Reduced 3.95%	607,142 $25.8 Million
Q3 2021 Nov 04, 2021	BUY	$40.26 - $57.37 $1.01 Million - $1.44 Million	25,177 Added 4.15%	632,087 $28 Million
Q2 2021 Aug 11, 2021	SELL	$54.88 - $79.29 $1.96 Million - $2.82 Million	-35,627 Reduced 5.54%	606,910 $34.5 Million
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $5.19 Million - $7.11 Million	-73,528 Reduced 10.27%	642,537 $48.1 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $25.8 Million - $39.3 Million	441,228 Added 160.54%	716,065 $61.9 Million
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $1.72 Million - $2.61 Million	-41,858 Reduced 13.22%	274,837 $16.8 Million
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $3.19 Million - $5.3 Million	-122,863 Reduced 27.95%	316,695 $13.2 Million
Q1 2020 May 14, 2020	BUY	$26.15 - $77.24 $2.07 Million - $6.13 Million	79,314 Added 22.02%	439,558 $12.6 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $14.2 Million - $36.5 Million	235,590 Added 189.0%	360,244 $26 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $3.06 Million - $4.15 Million	-21,826 Reduced 14.9%	124,654 $17.5 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $10.6 Million - $12.3 Million	67,147 Added 84.64%	146,480 $26.8 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $5.14 Million - $9.42 Million	-57,587 Reduced 42.06%	79,333 $12.6 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $2.93 Million - $5 Million	-35,756 Reduced 20.71%	136,920 $13.1 Million
Q3 2018 Dec 21, 2021	BUY	$138.11 - $169.04 $5.03 Million - $6.16 Million	36,452 Added 26.76%	172,676 $24.4 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $5.67 Million - $6.94 Million	-41,036 Reduced 23.15%	136,224 $19.2 Million
Q2 2018 Apr 21, 2020	BUY	$140.36 - $175.76 $1.66 Million - $2.08 Million	11,851 Added 7.16%	177,260 $27.7 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $19.4 Million - $24.3 Million	-138,486 Reduced 45.57%	165,409 $25.9 Million
Q1 2018 Oct 18, 2019	BUY	$152.15 - $192.33 $6.97 Million - $8.81 Million	45,832 Added 17.76%	303,895 $48.9 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $16.2 Million - $20.4 Million	106,284 Added 70.03%	258,063 $41.6 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $13.8 Million - $38 Million	-226,840 Reduced 59.91%	151,779 $25 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $23.2 Million - $33.5 Million	378,619	378,619 $23.6 Million

Others Institutions Holding SAGE

# of Institutions

Shares Held

6.2M

Call Options Held

37.8K

Put Options Held

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account